BackTable / Urology / Podcast / Episode #160

The Evolution of Bladder Cancer Treatment: New Insights on Lymphadenectomy

with Dr. Seth Paul Lerner

This week on BackTable Urology, Dr. Seth Lerner (Baylor College of Medicine) discusses the intricacies of lymph node dissection in bladder cancer management, including an overview of patterns of metastasis, genomic classifiers, and recent clinical trials.

This podcast is supported by:

Veracyte

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

The Evolution of Bladder Cancer Treatment: New Insights on Lymphadenectomy with Dr. Seth Paul Lerner on the BackTable Urology Podcast

Ep 160 The Evolution of Bladder Cancer Treatment: New Insights on Lymphadenectomy with Dr. Seth Paul Lerner

00:00 / 01:04

BackTable, LLC (Producer). (2024, April 9). Ep. 160 – The Evolution of Bladder Cancer Treatment: New Insights on Lymphadenectomy [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Seth Paul Lerner

Dr. Seth Paul Lerner is a professor of urology with Baylor College of Medicine in Houston, Texas.

Synopsis

The discussion highlights the evolution of bladder cancer treatment, from the use of cytotoxic chemotherapy to the current practice of neoadjuvant chemotherapy and radical cystectomy. Dr. Lerner and Dr. Bagrodia further explore diagnostic and treatment strategies, including the role of Decipher Prostate Genomic Classifier in tailoring patient treatment plans. The podcast delves into the necessity of a multidisciplinary approach to bladder cancer, the benefits of multimodal therapy, and the integration of circulating tumor DNA in management plans. Dr. Lerner then discusses clinical trials assessing the impact of extended lymph node dissection during cystectomies and emphasizes the importance of surgical quality and adherence to established protocols in bladder cancer treatment.

Timestamps

00:00 - Introduction
06:17 - The Role of Imaging in Bladder Cancer Staging
08:00 - Exploring the Potential of Genomic Classifiers
16:55 - Debating the Efficacy of Extended Lymph Node Dissection
27:47 - Update on Bladder Cancer Clinical Trials
48:54 - Final Thoughts and the Future of Bladder Cancer Treatment

Read Transcript

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

Genomic Classifiers in Bladder Cancer Management with Dr. Carissa Chu on the BackTable Urology Podcast

NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast

NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast

Techniques & Challenges in Bladder Transplant Surgery with Dr. Nima Nassiri on the BackTable Urology Podcast

Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue on the BackTable Urology Podcast

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Topics

Retroperitoneal Lymph Node Dissection (RPLND) Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.